Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Hear Stephen A. Harrison, MD, COL (Ret.), FAASLD, weigh the latest perspectives on wet biomarkers, imaging, and combination tests in NASH, including their use in:
Download the slides from this podcast at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics/noninvasive-testing-now-and-in-the-future/slideset
See more NASH topics at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics
Rotonya Carr, MD, explores the evidence behind different diets in NAFLD/NASH: ketogenic diet, Mediterranean diet, and more for CCO
Hear CCO faculty Philip Newsome discuss the agents in late-phase clinical trials and their potential use in treatment of NASH and fibrosis
CCO faculty Dr Juan Frias discusses the agents in late-phase clinical trials and their potential use in treatment of NASH and fibrosis
Juan Frias and Philip Newsome: Learn about the agents in phase II and III clinical trials and their potential use in treatment.